Validation of a solid-phase electrochemical array for genotyping hepatitis C virus

Experimental and Molecular Pathology

Volumn 95, Issue 1, 2013, Pages 18-22

  Sam, Soya S ^a,b,c   Steinmetz, Heather B ^a,b,c   Tsongalis, Gregory J ^a,b,c   Tafe, Laura J ^a,b,c   Lefferts, Joel A ^a,b,c  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b NORRIS COTTON CANCER CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

ESensor XT 8 system; Genotyping; HCV infection; Viral load

Indexed keywords

5' UNTRANSLATED REGION; AMPLICON; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; GENOTYPE; HEPATITIS C VIRUS; HUMAN; LABORATORY DEVICE; LIMIT OF DETECTION; MICROARRAY ANALYSIS; NONHUMAN; PERFORMANCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SOLID PHASE ELECTROCHEMICAL ARRAY; VALIDATION STUDY;

ESENSOR XT-8 SYSTEM; GENOTYPING; HCV INFECTION; VIRAL LOAD;

5' UNTRANSLATED REGIONS; ELECTROCHEMISTRY; GENOTYPING TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HUMANS; LIMIT OF DETECTION; SENSITIVITY AND SPECIFICITY;

EID: 84877799681     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.04.001     Document Type: Article

References (32)

1. Akamatsu N., Sugawara Y. Liver transplantation and hepatitis C. International Journal of Hepatology 2012, 2012:686135.
2. Bosch F.X., Ribes J., Diaz M., et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127:S5-S16.
3. Carcamo W.C., Nguyen C.Q. Advancement in the development of models for hepatitis C research. Journal of Biomedicine and Biotechnology 2012, 2012:346761.
4. Chak E., Talal A.H., Sherman K.E., et al. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver International 2011, 31:1090-1101.
5. Chen S.L., Morgan T.R. The natural history of hepatitis C virus (HCV) infection. International Journal of Medical Sciences 2006, 3:47-52.
6. Choo Q.L., Richman K.H., Han J.H., et al. Genetic organization and diversity of the hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:2451-2455.
7. El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142:1264-1273.
8. Grebely J., Prins M., Hellard M., et al. International collaboration of incident HIV and hepatitis C in injecting cohorts (InC3): hepatitis C virus clearance, reinjection, and persistence, with insights from studies of injecting drug users: towards a vaccine. The Lancet Infectious Diseases 2012, 12:408-414.
9. Jacobson I.M., McHutchison J.G., Dusheiko G., et al. ADVANCE Study Team: Telaprevir for previously untreated chronic hepatitis C virus infection. The New England Journal of Medicine 2011, 364:2405-2416.
10. Jahan S., Khaliq S., Ijaz B., et al. Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis. Virology Journal 2011, 8:155.
11. Klevens R.M., Hu D.J., Jiles R., et al. Evolving epidemiology of hepatitis C virus in the United States. Clinical Infectious Diseases 2012, 55:S3-S9.
12. Kupfer B. HCV Virology. Hepatology 2012, 85-107. Flying, Germany. S. Mauss, T. Berg, J. Rockstroh, C. Sarrazin, H. Wedemeyer (Eds.).
13. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection 2011, 17:107-115.
14. Ly K.N., Xing J., Klevens R.M., et al. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Annals of Internal Medicine 2012, 156:271-278.
15. Maertens G., Stuyver L. HCV genotyping by the line probe assay iNNO-LiPA HCV II. Methods in Molecular Medicine 1999, 19:183-198.
16. Morgan T.R., O'Brien T.R. IL28B-genotype testing now and in the era of direct-acting antiviral agents. Clinical Gastroenterology and Hepatology 2011, 9:293-294.
17. Muerhoff A.S., Leary T.P., Simons J.N., et al. Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. Journal of Virology 1995, 69:5621-5630.
18. Murphy D.G., Willems B., Deschenes M., et al. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. Journal of Clinical Microbiology 2007, 45:1102-1112.
19. Pacanowski M., Amur S., Zineh I. New genetic discoveries and treatment for hepatitis C. Journal of the American Medical Association 2012, 307:1921-1922.
20. Pearlman B.L. Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care. The Lancet Infectious Diseases 2012, 12:717-728.
21. Penin F., Dubuisson J., Rey F.A., et al. Structural biology of hepatitis C virus. Hepatology 2004, 39:5-19.
22. Pierce V.M., Hodinka R.L. Comparison of the GenMark Diagnostics eSensor respiratory viral panel to real-time PCR for detection of respiratory viruses in children. Journal of Clinical Microbiology 2012, 50:3458-3465.
23. Poordad F., Dieterich D. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents. Journal of Viral Hepatitis 2012, 19:449-464.
24. Poordad F., McCone J., Bacon B.R., et al. SPRINT-2 Investigators: Boceprevir for untreated chronic HCV genotype 1 infection. The New England Journal of Medicine 2011, 364:1195-1206.
25. Prati D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. Journal of Hepatology 2006, 45:607-616.
26. Shi S.T., Lai M.M.C. HCV 5' and 3' UTR: when translation meets replication. Hepatitis C Viruses: Genomes and Molecular Biology 2006, 49-87. Horizon Bioscience, Norfolk (UK). S.L. Tan (Ed.).
27. Simmonds P., McOmish F., Yap P.L., et al. Sequence variability in the 5' non-coding region of hepatitis C virus: identification of new virus type and restriction sequence diversity. Journal of General Virology 1993, 74:661-668.
28. Simmonds P., Bukh J., Combet C., et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005, 42:962-973.
29. Sizmann D., Boeck C., Boelter J., et al. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system. Journal of Clinical Virology 2007, 38:326-333.
30. Spradling P.R., Rupp L., Moorman A.C., et al. Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. Clinical Infectious Diseases 2012, 55:1047-1055.
31. Torres H.A., Nevah M.I., Barnett B.J., et al. Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: a retrospective multicenter study. Journal of Clinical Virology 2012, 54:218-222.
32. Yang J.D., Kim B., Sanderson S.O., et al. Hepatocellular carcinoma in Olmsted County, Minnesota, 1976-2008. Mayo Clinic Proceedings 2012, 87:9-16.